日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Minimally expanded breast cancer tumor-infiltrating-lymphocytes provide guidance for therapeutic selection

最小扩增的乳腺癌肿瘤浸润淋巴细胞可为治疗选择提供指导。

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2025.1699262
Aran, Andrea; Lázaro, Gonzalo; Marco, Vicente; Peg, Vicente; Faus, Maitane; Garrigós, Laia; Pérez-García, José; Cortés, Javier; Martí, Mercè
细胞生物学
肿瘤
肿瘤免疫
乳腺癌
发表日期：2025
文献求助 收藏

Biomarkers in breast cancer 2024: an updated consensus statement by the Spanish Society of Medical Oncology and the Spanish Society of Pathology

2024年乳腺癌生物标志物：西班牙肿瘤内科学会和西班牙病理学会的最新共识声明

期刊:Clinical & Translational Oncology
影响因子:2.5
doi:10.1007/s12094-024-03541-1
Colomer, Ramon; González-Farré, Blanca; Ballesteros, Ana Isabel; Peg, Vicente; Bermejo, Begoña; Pérez-Mies, Belén; de la Cruz, Susana; Rojo, Federico; Pernas, Sonia; Palacios, José
肿瘤
肿瘤免疫
乳腺癌
发表日期：2024
文献求助 收藏

Clinical application of the HM-1000 image processing for HER2 fluorescence in situ hybridization signal quantification in breast cancer

HM-1000图像处理技术在乳腺癌HER2荧光原位杂交信号定量中的临床应用

期刊:Diagnostic Pathology
影响因子:2.3
doi:10.1186/s13000-024-01455-8
Peg, Vicente; Moline, Teresa; Roig, Miquel; Saruta, Yuko; Cajal, Santiago Ramon Y
肿瘤
IF
HER2
肿瘤免疫
信号转导
乳腺癌
发表日期：2024
文献求助 收藏

Author Correction: Clinical, pathological, and PAM50 gene expression features of HER2-low breast cancer

作者更正：HER2低表达乳腺癌的临床、病理和PAM50基因表达特征

期刊:NPJ Breast Cancer
影响因子:7.6
doi:10.1038/s41523-023-00538-x
Schettini, Francesco; Chic, Nuria; Brasó-Maristany, Fara; Paré, Laia; Pascual, Tomás; Conte, Benedetta; Martínez-Sáez, Olga; Adamo, Barbara; Vidal, Maria; Barnadas, Esther; Fernández-Martinez, Aranzazu; González-Farre, Blanca; Sanfeliu, Esther; Cejalvo, Juan Miguel; Perrone, Giuseppe; Sabarese, Giovanna; Zalfa, Francesca; Peg, Vicente; Fasani, Roberta; Villagrasa, Patricia; Gavilá, Joaquín; Barrios, Carlos H; Lluch, Ana; Martín, Miguel; Locci, Mariavittoria; De Placido, Sabino; Prat, Aleix
HER2
肿瘤
肿瘤免疫
乳腺癌
发表日期：2023
文献求助 收藏

Analysis of tumor infiltrating CD4+ and CD8+ CDR3 sequences reveals shared features putatively associated to the anti-tumor immune response

对肿瘤浸润性 CD4+ 和 CD8+ CDR3 序列的分析揭示了可能与抗肿瘤免疫反应相关的共同特征。

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2023.1227766
Aran, Andrea; Lázaro, Gonzalo; Marco, Vicente; Molina, Elisa; Abancó, Ferran; Peg, Vicente; Gión, María; Garrigós, Laia; Pérez-García, José; Cortés, Javier; Martí, Mercè
T细胞
CD4
CD8
免疫/内分泌
肿瘤
肿瘤免疫
发表日期：2023
文献求助 收藏

Matrix Metalloproteinase-9 Expression Is Associated with the Absence of Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer Patients

基质金属蛋白酶-9表达与三阴性乳腺癌患者新辅助化疗无反应相关

期刊:International Journal of Molecular Sciences
影响因子:4.9
doi:10.3390/ijms241411297
Lejeune, Marylène; Reverté, Laia; Gallardo, Noèlia; Sauras, Esther; Bosch, Ramon; Mata, Daniel; Roso, Albert; Petit, Anna; Peg, Vicente; Riu, Francisco; García-Fontgivell, Joan; Relea, Fernanda; Vieites, Begoña; de la Cruz-Merino, Luis; Arenas, Meritxell; Rodriguez, Valeri; Galera, Juana; Korzynska, Anna; Plancoulaine, Benoît; Álvaro, Tomás; López, Carlos
乳腺癌
肿瘤免疫
肿瘤
发表日期：2023
文献求助 收藏

Prognostic Implications of the Residual Tumor Microenvironment after Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer Patients without Pathological Complete Response

新辅助化疗后残余肿瘤微环境对未达到病理完全缓解的三阴性乳腺癌患者的预后意义

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers15030597
Lejeune, Marylène; Reverté, Laia; Sauras, Esther; Gallardo, Noèlia; Bosch, Ramon; Roso, Albert; Petit, Anna; Peg, Vicente; Riu, Francisco; García-Fontgivell, Joan; Ibáñez, José; Relea, Fernanda; Vieites, Begoña; Bor, Catherine; de la Cruz-Merino, Luis; Arenas, Meritxell; Rodriguez, Valerie; Galera, Juana; Korzynska, Anna; Belhomme, Philippe; Plancoulaine, Benoît; Álvaro, Tomás; López, Carlos
肿瘤微环境
乳腺癌
肿瘤免疫
肿瘤
发表日期：2023
文献求助 收藏

Clearance of ctDNA in triple-negative and HER2-positive breast cancer patients during neoadjuvant treatment is correlated with pathologic complete response

在接受新辅助治疗的三阴性乳腺癌和HER2阳性乳腺癌患者中，ctDNA的清除与病理完全缓解相关。

期刊:Therapeutic Advances in Medical Oncology
影响因子:4.2
doi:10.1177/17588359221139601
Ciriaco, Nikaoly; Zamora, Esther; Escrivá-de-Romaní, Santiago; Miranda Gómez, Ignacio; Jiménez Flores, José; Saura, Cristina; Sloane, Hillary; Starus, Anna; Fredebohm, Johannes; Georgieva, Lucy; Speight, Graham; Jones, Frederick; Ramón Y Cajal, Santiago; Espinosa-Bravo, Martín; Peg, Vicente
HER2
肿瘤
肿瘤免疫
乳腺癌
发表日期：2022
文献求助 收藏

Genetic and functional homologous repair deficiency as biomarkers for platinum sensitivity in TNBC: A case report

遗传和功能性同源修复缺陷作为三阴性乳腺癌铂类药物敏感性的生物标志物：病例报告

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2022.963728
Gomez-Puerto, Diego; Llop-Guevara, Alba; Cruellas, Mara; Torres-Esquius, Sara; De La Torre, Javier; Peg, Vicente; Balmaña, Judith; Pimentel, Isabel
肿瘤
肿瘤免疫
乳腺癌
发表日期：2022
文献求助 收藏

Clinical, pathological, and PAM50 gene expression features of HER2-low breast cancer

HER2低表达乳腺癌的临床、病理及PAM50基因表达特征

期刊:NPJ Breast Cancer
影响因子:7.6
doi:10.1038/s41523-020-00208-2
Schettini, Francesco; Chic, Nuria; Brasó-Maristany, Fara; Paré, Laia; Pascual, Tomás; Conte, Benedetta; Martínez-Sáez, Olga; Adamo, Barbara; Vidal, Maria; Barnadas, Esther; Fernández-Martinez, Aranzazu; González-Farre, Blanca; Sanfeliu, Esther; Cejalvo, Juan Miguel; Perrone, Giuseppe; Sabarese, Giovanna; Zalfa, Francesca; Peg, Vicente; Fasani, Roberta; Villagrasa, Patricia; Gavilá, Joaquín; Barrios, Carlos H; Lluch, Ana; Martín, Miguel; Locci, Mariavittoria; De Placido, Sabino; Prat, Aleix
HER2
肿瘤
肿瘤免疫
乳腺癌
发表日期：2021
文献求助 收藏